Bao-Zhu Yuan

Title: The Innovations of Bao-Zhu Yuan

Introduction

Bao-Zhu Yuan is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of cancer research, particularly through his work on the DLC-1 gene. With a total of 2 patents, Yuan's innovations are paving the way for advancements in cancer diagnosis and treatment.

Latest Patents

Yuan's latest patents focus on the DLC-1 gene, which is frequently deleted in liver cancer cells and cell lines. This newly discovered human gene is believed to act as a tumor suppressor, as it is present in normal cells but often absent in cancerous ones. The gene is also associated with breast and colon cancers, where its expression is decreased or undetectable. His patents disclose the amino acid sequence of the protein encoded by the DLC-1 gene and present methods for using these biological materials in the diagnosis and treatment of various cancers, including hepatocellular cancer, breast cancer, colon cancer, prostate cancer, and adenocarcinomas.

Career Highlights

Yuan works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His research has contributed to a better understanding of cancer biology and potential therapeutic approaches.

Collaborations

Yuan has collaborated with notable colleagues, including Nicholas Popescu and Snorri S Thorgeirsson. Their combined expertise enhances the impact of their research in the field of oncology.

Conclusion

Bao-Zhu Yuan's work on the DLC-1 gene represents a significant advancement in cancer research. His contributions are vital for developing new diagnostic and therapeutic strategies for various cancers.